This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Other. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: Innovations in Hematopoietic Disorder Treatment by Basan Gowda S Kurkalli
Introduction
Basan Gowda S Kurkalli is an innovative inventor based in Jerusalem, Israel. He has made significant contributions to the field of hematopoietic disorders through his research and inventions. His work focuses on improving treatment methods for conditions affecting blood cell formation and function.
Latest Patents
Basan Gowda S Kurkalli holds a patent for "Methods of treatment of hematopoietic disorders." This patent describes a composition comprising bone marrow cells (BMC) and demineralized bone matrix (DBM) and/or mineralized bone matrix (MBM). The invention is particularly useful for bone marrow transplantation, either into the bone marrow cavity or extraskeletal sites. The methods enable the restoration and enhancement of the hematopoietic microenvironment originating from the transplanted BMC. This innovation is beneficial for treating various hematopoietic disorders, including stem cell deficiencies and genetic conditions affecting stem cells.
Career Highlights
Throughout his career, Basan Gowda S Kurkalli has focused on developing methods that enhance the treatment of hematopoietic disorders. His work has the potential to improve patient outcomes significantly. He has been recognized for his contributions to the field and continues to be an active participant in research and development.
Collaborations
Basan Gowda S Kurkalli has collaborated with notable professionals in his field, including Shimon Slavin and Olga Gurevitch. These collaborations have furthered his research and contributed to the advancement of treatment methods for hematopoietic disorders.
Conclusion
Basan Gowda S Kurkalli's innovative work in the treatment of hematopoietic disorders showcases the importance of research and development in medical science. His patent and collaborations highlight the potential for improved therapies that can significantly impact patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile